Title: The unique antiviral activity of artesunate is broadly effective against human cytomegaloviruses including therapy-resistant mutants.
Journal: Antiviral research 20111101
Title: Genotypic characterization of human cytomegalovirus UL97 phosphotransferase natural polymorphism in the era of ganciclovir and maribavir.
Journal: Antiviral research 20110701
Title: Antiviral inhibition targeting the HCMV kinase pUL97 requires pUL27-dependent degradation of Tip60 acetyltransferase and cell-cycle arrest.
Journal: Cell host & microbe 20110217
Title: Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients.
Journal: Transplant infectious disease : an official journal of the Transplantation Society 20101201
Title: Leflunomide: a small step forward in meeting the urgent need for treatment of drug-resistant cytomegalovirus infection.
Journal: Transplantation 20100827
Title: Virologic characterization of multidrug-resistant cytomegalovirus infection in 2 transplant recipients treated with maribavir.
Journal: The Journal of infectious diseases 20100701
Title: Antiviral prophylaxis in haematological patients: systematic review and meta-analysis.
Journal: European journal of cancer (Oxford, England : 1990) 20091201
Title: A randomized, double-blind, pharmacokinetic study of oral maribavir with tacrolimus in stable renal transplant recipients.
Journal: American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20091001
Title: Function of human cytomegalovirus UL97 kinase in viral infection and its inhibition by maribavir.
Journal: Reviews in medical virology 20090701
Title: Conserved retinoblastoma protein-binding motif in human cytomegalovirus UL97 kinase minimally impacts viral replication but affects susceptibility to maribavir.
Journal: Virology journal 20090101
Title: Viral mimicry of Cdc2/cyclin-dependent kinase 1 mediates disruption of nuclear lamina during human cytomegalovirus nuclear egress.
Journal: PLoS pathogens 20090101
Title: Conserved domains and structure prediction of human cytomegalovirus UL27 protein.
Journal: Antiviral therapy 20090101
Title: Maribavir: a novel antiviral agent with activity against cytomegalovirus.
Journal: The Annals of pharmacotherapy 20081001
Title: Cytomegalovirus infection after liver transplantation: current concepts and challenges.
Journal: World journal of gastroenterology 20080821
Title: Maribavir prophylaxis for prevention of cytomegalovirus infection in allogeneic stem cell transplant recipients: a multicenter, randomized, double-blind, placebo-controlled, dose-ranging study.
Journal: Blood 20080601
Title: Expression of the human cytomegalovirus UL97 gene in a chimeric guinea pig cytomegalovirus (GPCMV) results in viable virus with increased susceptibility to ganciclovir and maribavir.
Journal: Antiviral research 20080601
Title: Prevention and early treatment of opportunistic viral infections in patients with leukemia and allogeneic stem cell transplantation recipients.
Journal: Journal of the National Comprehensive Cancer Network : JNCCN 20080201
Title: Cytomegalovirus UL97 mutations in the era of ganciclovir and maribavir.
Journal: Reviews in medical virology 20080101
Title: Cytomegalovirus UL97 kinase mutations that confer maribavir resistance.
Journal: The Journal of infectious diseases 20070701
Title: Pharmacokinetics of maribavir, a novel oral anticytomegalovirus agent, in subjects with varying degrees of renal impairment.
Journal: Journal of clinical pharmacology 20070201
Title: Maribavir: 1263W94, Benzimidavir, GW 1263, GW 1263W94, VP41263.
Journal: Drugs in R&D 20070101
Title: Maribavir sensitivity of cytomegalovirus isolates resistant to ganciclovir, cidofovir or foscarnet.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20061001
Title: N-methylpurine DNA glycosylase and 8-oxoguanine dna glycosylase metabolize the antiviral nucleoside 2-bromo-5,6-dichloro-1-(beta-D-ribofuranosyl)benzimidazole.
Journal: Drug metabolism and disposition: the biological fate of chemicals 20060601
Title: [Therapeutic approach to EBV infection].
Journal: Nihon rinsho. Japanese journal of clinical medicine 20060301
Title: In vitro activity and mechanism of action of methylenecyclopropane analogs of nucleosides against herpesvirus replication.
Journal: Antimicrobial agents and chemotherapy 20050301
Title: Inhibition of human cytomegalovirus replication by benzimidazole nucleosides involves three distinct mechanisms.
Journal: Antimicrobial agents and chemotherapy 20041001
Title: Mechanism of action of the ribopyranoside benzimidazole GW275175X against human cytomegalovirus.
Journal: Antimicrobial agents and chemotherapy 20040501
Title: Activities of benzimidazole D- and L-ribonucleosides in animal models of cytomegalovirus infections.
Journal: Antimicrobial agents and chemotherapy 20040501
Title: Effects of maribavir and selected indolocarbazoles on Epstein-Barr virus protein kinase BGLF4 and on viral lytic replication.
Journal: Antimicrobial agents and chemotherapy 20040501
Title: In vitro activities of benzimidazole D- and L-ribonucleosides against herpesviruses.
Journal: Antimicrobial agents and chemotherapy 20030701
Title: Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.
Journal: Antimicrobial agents and chemotherapy 20030401
Title: Resistance of human cytomegalovirus to D- and L-ribosyl benzimidazoles as a tool to identify potential targets for antiviral drugs.
Journal: Nucleosides, nucleotides & nucleic acids 20030101
Title: Interactions among antiviral drugs acting late in the replication cycle of human cytomegalovirus.
Journal: Antiviral research 20021001
Title: Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action.
Journal: Antimicrobial agents and chemotherapy 20020801
Title: Inhibition of ganciclovir-susceptible and -resistant human cytomegalovirus clinical isolates by the benzimidazole L-riboside 1263W94.
Journal: Clinical and diagnostic laboratory immunology 20011101
Title: A novel nonnucleoside inhibitor specifically targets cytomegalovirus DNA maturation via the UL89 and UL56 gene products.
Journal: Journal of virology 20011001
Title: Synthesis and antiviral evaluation of halogenated beta-D- and -L-erythrofuranosylbenzimidazoles.
Journal: Journal of medicinal chemistry 20000615
Title: Synthesis and evaluation of a series of 2'-deoxy analogues of the antiviral agent 5,6-dichloro-2-isopropylamino-1-(beta-L-ribofuranosyl)-1H-benzimidazole (1263W94).
Journal: Nucleosides, nucleotides & nucleic acids 20000101
Title: Inhibition of Epstein-Barr virus replication by a benzimidazole L-riboside: novel antiviral mechanism of 5, 6-dichloro-2-(isopropylamino)-1-beta-L-ribofuranosyl-1H-benzimidazole.
Journal: Journal of virology 19990901
Title: Human cytomegalovirus: challenges, opportunities and new drug development.
Journal: Antiviral chemistry & chemotherapy 19990901
Title: Development of novel benzimidazole riboside compounds for treatment of cytomegalovirus disease.
Journal: Advances in experimental medicine and biology 19990101
Title: Shannon-Lowe CD, et al. The effects of Maribavir on the autophosphorylation of ganciclovir resistant mutants of the cytomegalovirus UL97 protein. Herpesviridae. 2010 Dec 7;1(1):4.
Title: Biron KK, et al. Potent and selective inhibition of human cytomegalovirus replication by 1263W94, a benzimidazole L-riboside with a unique mode of action. Antimicrob Agents Chemother. 2002 Aug;46(8):2365-72.
